secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001654954-24-009069
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ZIVO Bioscience appoints Laith Yaldoo to board, expands to 5 members
--------------------------------------------------------------------

- Board increased from 4 to 5 members; Laith Yaldoo appointed effective July 11, 2024.
- Yaldoo is managing member of HEP Investments LLC; background in biotech, healthcare, and card processing.
- He will stand for election as a Class I director at the 2026 annual meeting.
- No family relationships or related party transactions with current officers/directors.
- Yaldoo will participate in the Company’s standard outside director compensation program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424009069/0001654954-24-009069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424009069/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-009069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer